Also trades as: TTALO.HE (HEL) · $vol 2M

$8.95

+0.00 (+0.00%)

OTC · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 41 · $1.1B mcap · 79M float · 0.0001% daily turnover · Short 100% of daily vol

Revenue

$1.3B -4.6% ▼

5Y CAGR: +5.3%

Gross Profit

$270M -65.9% ▼

5Y CAGR: -12.9%

Operating Income

$138M +18.5% ▲

5Y CAGR: +15.4%

Net Income

$93M +29.1% ▲

5Y CAGR: +15.1%

EPS (Diluted)

$0.73 +28.1% ▲

5Y CAGR: +15.2%

EBITDA

$233M +7.4% ▲

5Y CAGR: +8.1%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.2B	$1.3B	$1.3B	$1.3B	$1.3B
YoY Growth	+17.1%	+9.1%	+2.2%	+4.2%	-4.6%
Cost of Revenue	$489M	$526M	$983M	$550M	$1.0B
Gross Profit	$666M	$733M	$303M	$790M	$270M
Gross Margin	57.7%	58.2%	23.6%	59.0%	21.1%
R&D Expenses	$3M	$8M	$12M	$0	$0
SG&A Expenses	$7M	$8M	$9M	$11M	$132M
Operating Expenses	$553M	$667M	$318M	$674M	$132M
Operating Income	$110M	$34M	-$15M	$116M	$138M
Operating Margin	9.5%	2.7%	-1.1%	8.7%	10.8%
Interest Expense	$9M	$10M	$23M	$28M	$22M
Income Before Tax	$101M	$31M	-$39M	$90M	$116M
Tax Expense	$20M	$6M	$3M	$18M	$23M
Net Income	$80M	$24M	-$42M	$72M	$93M
Net Margin	7.0%	1.9%	-3.3%	5.4%	7.2%
EPS (Diluted)	$0.63	$0.19	$-0.33	$0.57	$0.73
EBITDA	$202M	$176M	$91M	$217M	$233M
Shares Outstanding	128M	127M	127M	127M	127M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$296M	$354M	$347M	$322M	$281M	$330M	$309M	$293M
Cost of Revenue	$122M	$144M	$138M	$128M	$226M	$262M	$247M	$121M
Gross Profit	$174M	$210M	$209M	$193M	$55M	$68M	$62M	$172M
Gross Margin	58.7%	59.2%	60.3%	60.1%	19.5%	20.6%	20.2%	58.8%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$3M	$3M	$4M	$3M	$30M	$37M	$3M	$4M
Operating Expenses	$149M	$179M	$163M	$160M	$30M	$37M	$35M	$149M
Operating Income	$25M	$31M	$46M	$33M	$25M	$31M	$27M	$23M
Operating Margin	8.5%	8.7%	13.4%	10.4%	8.7%	9.3%	8.8%	7.9%
Interest Expense	$8M	$7M	$5M	$5M	$6M	$6M	$5M	$5M
Income Before Tax	$18M	$24M	$41M	$28M	$20M	$27M	$22M	$17M
Tax Expense	$4M	$5M	$8M	$6M	$4M	$6M	$5M	$3M
Net Income	$15M	$19M	$33M	$22M	$16M	$21M	$17M	$14M
Net Margin	5.0%	5.4%	9.6%	6.9%	5.8%	6.3%	5.6%	4.7%
EPS (Diluted)	$0.12	$0.15	$0.26	$0.17	$0.13	$0.16	$0.14	$0.11
EBITDA	$51M	$60M	$70M	$57M	$49M	$59M	$51M	$47M
Shares Outstanding	127M	127M	127M	131M	127M	130M	127M	127M

TTALF OTC